EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Constitutive RLI Armoring Enhances CAR-NK Cell Effector Functions but Causes Lethal Toxicity In Vivo

Zhiming Ling, Yi Wang, Geping Wu iD, Wei Lin iD, Tao Lu, Guohua Yu iD, Jianxun Wang

International Journal of Molecular Sciences · 16.04.2026 · 27 (8) · 3554

DOI: 10.3390/ijms27083554 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.04.2026. Verfasst von Zhiming Ling und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science, Beijing University of Chinese Medicine, Beijing 102488, China. Hauptthemen laut MEDLINE: Killer Cells, Natural, Interleukin-15, Immunotherapy, Adoptive, Receptors, Chimeric Antigen. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric antigen receptor–natural killer (CAR-NK) cell therapy is a promising immunotherapy for hematological malignancies. While engineered interleukin15 (IL15) variants like membrane-bound IL15 (mbIL15) and the IL15/IL15Rα heterodimer (RLI) can enhance NK cell activity, their relative efficacy and safety as armor for CAR-NK cells remain unclear. This study systematically evaluated primary human CAR-NK cells co-expressing an anti-CD19 CAR (19ζ) with soluble IL15, mbIL15, or RLI. We found that 19ζ-RLI CAR-NK cells exhibited superior IL15 secretion, proliferation, cytotoxicity, and migration in vitro, and effectively controlled tumors in vivo. However, all IL15-armored constructs, particularly 19ζ-RLI, induced lethal toxicity in mice, characterized by CAR-NK hyperproliferation and elevated systemic IL15. Transcriptomic analysis revealed that this toxicity correlated with a hyperactive molecular state driven by persistent IL15 signaling. In conclusion, this study suggests that constitutive IL15 armoring can be a potent but risky strategy for enhancing CAR-NK cells, with RLI being the most potent yet toxic exemplar of this general principle. Our findings highlight the necessity of incorporating safety-optimized strategies, such as inducible cytokine expression, into the design of cytokine-armored CAR-NK therapies for clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Killer Cells, NaturalInterleukin-15Immunotherapy, AdoptiveReceptors, Chimeric AntigenInterleukin-15 Receptor alpha SubunitAnimalsHumansMiceCell Proliferation

Stichwörter der Autor:innen

B-cell malignanciesCAR-NKIL15RLIadoptive cell therapymbIL15toxicity

Substanzen

Interleukin-15Receptors, Chimeric AntigenInterleukin-15 Receptor alpha SubunitIL15 protein, human

Autor:innen und Institutionen

  • School of Life Science, Beijing University of Chinese Medicine, Beijing 102488, China.

ORCID-Profile: Geping Wu, Wei Lin, Guohua Yu

Zitieren

APA

Ling, Z., Wang, Y., Wu, G., Lin, W., Lu, T., Yu, G., & Wang, J. (2026). Constitutive RLI Armoring Enhances CAR-NK Cell Effector Functions but Causes Lethal Toxicity In Vivo. International Journal of Molecular Sciences, 27(8), 3554. https://doi.org/10.3390/ijms27083554

Vancouver

Ling Z, Wang Y, Wu G, Lin W, Lu T, Yu G, et al. Constitutive RLI Armoring Enhances CAR-NK Cell Effector Functions but Causes Lethal Toxicity In Vivo. International Journal of Molecular Sciences. 2026;27(8):3554. doi:10.3390/ijms27083554

BibTeX
@article{Ling2026,
  author = {Ling, Zhiming and Wang, Yi and Wu, Geping and Lin, Wei and Lu, Tao and Yu, Guohua and Wang, Jianxun},
  title = {Constitutive RLI Armoring Enhances CAR-NK Cell Effector Functions but Causes Lethal Toxicity In Vivo},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {8},
  pages = {3554},
  doi = {10.3390/ijms27083554}
}
Kostenlos starten →